Skip to Main Content

Author Details

Phuoc T Tran
University of Maryland School of Medicine
1996
207
49
PMIDPaper TitleJournal TitlePublished Year
37748118Metastasis-Directed Therapy: A Moving Target Advancing Progress Forward.J Clin Oncol2024
37558543Identification of a Predictive Genomic Biomarker for Prostate-directed Therapy in Synchronous Low-volume Metastatic Castration-sensitive Prostate Cancer.Eur Urol Oncol2024
36316967The impact of salvage radiotherapy initiation at PSA⿿⿤⿿0.5⿿ng/ml on metastasis-free survival in patients with relapsed prostate cancer following prostatectomy.Prostate2023
37566929Cell-free DNA sequencing sheds additional insights on BRCA-altered metastatic castration-resistant prostate cancer.EBioMedicine2023
37060201A novel prostate cancer subtyping classifier based on luminal and basal phenotypes.Cancer2023
37173210Clinical and Genomic Differences Between Advanced Molecular Imaging-detected and Conventional Imaging-detected Metachronous Oligometastatic Castration-sensitive Prostate Cancer.Eur Urol2023
37137444Genomic Classifier Performance in Intermediate-Risk Prostate Cancer: Results From NRG Oncology/RTOG 0126 Randomized Phase 3 Trial.Int J Radiat Oncol Biol Phys2023
37364800FLASH Effects Induced by Orthovoltage X-Rays.Int J Radiat Oncol Biol Phys2023
37331778Histology Specific Molecular Biomarkers: Ushering in a New Era of Precision Radiation Oncology.Semin Radiat Oncol2023
36752776Griseofulvin Radiosensitizes Non-Small Cell Lung Cancer Cells and Activates cGAS.Mol Cancer Ther2023
36717286A Phase 1 Trial of Durvalumab in Combination with Bacillus Calmette-Guerin (BCG) or External Beam Radiation Therapy in Patients with BCG-unresponsive Non-muscle-Invasive Bladder Cancer: The Hoosier Cancer Research Network GU16-243 ADAPT-BLADDER Study.Eur Urol2023
36708787WNT Pathway Mutations in Metachronous Oligometastatic Castration-Sensitive Prostate Cancer.Int J Radiat Oncol Biol Phys2023
36596347Analysis of a Biopsy-Based Genomic Classifier in High-Risk Prostate Cancer: Meta-Analysis of the NRG Oncology/Radiation Therapy Oncology Group 9202, 9413, and 9902 Phase 3 Randomized Trials.Int J Radiat Oncol Biol Phys2023
36179990External Beam Radiation Therapy With or Without Brachytherapy Boost in Men With Very-High-Risk Prostate Cancer: A Large Multicenter International Consortium Analysis.Int J Radiat Oncol Biol Phys2023
36369671Evaluating potential overuse of surveillance care in cancer survivors.Cancer Med2023
36367998Phase II Randomized Study of Salvage Radiation Therapy Plus Enzalutamide or Placebo for High-Risk Prostate-Specific Antigen Recurrent Prostate Cancer After Radical Prostatectomy: The SALV-ENZA Trial.J Clin Oncol2023
36283936Review of Prospective Trials Assessing the Role of Stereotactic Body Radiation Therapy for Metastasis-directed Treatment in Oligometastatic Genitourinary Cancers.Eur Urol Oncol2023
34296383Implementing survivorship care planning in two contrasting health systems: lessons learned from a randomized controlled trial.J Cancer Surviv2022
35478055Interim analysis of companion, prospective, phase II, clinical trials assessing the efficacy and safety of multi-modal total eradication therapy in men with synchronous oligometastatic prostate cancer.Med Oncol2022
35641349Paving the Road to the Future of Chemoradiotherapy in Muscle-invasive Bladder Cancer: 10-year Follow-up of BC2001.Eur Urol2022
35657158Genomic biomarkers to guide precision radiotherapy in prostate cancer.Prostate2022
36001857Long-Term Outcomes and Genetic Predictors of Response to Metastasis-Directed Therapy Versus Observation in Oligometastatic Prostate Cancer: Analysis of STOMP and ORIOLE Trials.J Clin Oncol2022
36244393From Idea to Clinical Practice: A Brief History of Oligometastatic Disease.Int J Radiat Oncol Biol Phys2022
36244387Stereotactic Body Radiation Therapy for Oligometastasis: GUst Do It?Int J Radiat Oncol Biol Phys2022
35923127Prostate cancer grade downgrading at time of prostatectomy provides risk-stratification insight into future tumor behavior after prostatectomy.Prostate2022
36251389The 5-Hydroxymethylcytosine Landscape of Prostate Cancer.Cancer Res2022
35014708Radiating the prostate bed in relapsed oligometastatic prostate cancer: How comprehensive should we be?Prostate2022
35013522Definitions of disease burden across the spectrum of metastatic castration-sensitive prostate cancer: comparison by disease outcomes and genomics.Prostate Cancer Prostatic Dis2022
35058322The Promise of Metastasis-Directed Therapy for Oligometastatic Prostate Cancer: Going Beneath the Surface with Molecular Imaging.J Nucl Med2022
34990726Germline variants disrupting microRNAs predict long-term genitourinary toxicity after prostate cancer radiation.Radiother Oncol2022
35050303Interplay Between Duration of Androgen Deprivation Therapy and External Beam Radiotherapy With or Without a Brachytherapy Boost for Optimal Treatment of High-risk Prostate Cancer: A Patient-Level Data Analysis of 3 Cohorts.JAMA Oncol2022
34731491BCG invokes superior STING-mediated innate immune response over radiotherapy in a carcinogen murine model of urothelial cancer.J Pathol2022
34302474Simplifying Survivorship Care Planning: A Randomized Controlled Trial Comparing 3 Care Plan Delivery Approaches.J Natl Cancer Inst2022
30836168Immunomodulatory Effects of Stereotactic Body Radiation Therapy: Preclinical Insights and Clinical Opportunities.Int J Radiat Oncol Biol Phys2021
33570548Validation of a 22-Gene Genomic Classifier in Patients With Recurrent Prostate Cancer: An Ancillary Study of the NRG/RTOG 9601 Randomized Clinical Trial.JAMA Oncol2021
33713497Twist1 is required for the development of UVB-induced squamous cell carcinoma.Mol Carcinog2021
33484754The hexosamine biosynthetic pathway and cancer: Current knowledge and future therapeutic strategies.Cancer Lett2021
33755233What are survivorship care plans failing to tell men after prostate cancer treatment?Prostate2021
34902034Performance of a Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography-Derived Risk-Stratification Tool for High-risk and Very High-risk Prostate Cancer.JAMA Netw Open2021
34801437Tissue- and Blood-derived Genomic Biomarkers for Metastatic Hormone-sensitive Prostate Cancer: A Systematic Review.Eur Urol Oncol2021
34129855Transcriptional profiling of primary prostate tumor in metastatic hormone-sensitive prostate cancer and association with clinical outcomes: correlative analysis of the E3805 CHAARTED trial.Ann Oncol2021
34273331In Reply to Onal et al.Int J Radiat Oncol Biol Phys2021
33985797Patterns of Clinical Progression in Radiorecurrent High-risk Prostate Cancer.Eur Urol2021
34090651Local Therapies in Oligometastatic and Oligoprogressive Prostate Cancer.Semin Radiat Oncol2021
34196715Comparison of Multimodal Therapies and Outcomes Among Patients With High-Risk Prostate Cancer With Adverse Clinicopathologic Features.JAMA Netw Open2021
33452011(Oligo)metastasis as a Spectrum of Disease.Cancer Res2021
33451978Randomized Phase II Trial of Sipuleucel-T with or without Radium-223 in Men with Bone-metastatic Castration-resistant Prostate Cancer.Clin Cancer Res2021
33419682The Mutational Landscape of Metastatic Castration-sensitive Prostate Cancer: The Spectrum Theory Revisited.Eur Urol2021
32861817NRG Oncology Updated International Consensus Atlas on Pelvic Lymph Node Volumes for Intact and Postoperative Prostate Cancer.Int J Radiat Oncol Biol Phys2021
32798608Patterns of Recurrence and Modes of Progression After Metastasis-Directed Therapy in Oligometastatic Castration-Sensitive Prostate Cancer.Int J Radiat Oncol Biol Phys2021
  • 1 - 50 of 207

Recommended Authors

Soumyajit Roy
Rush University Medical Center
Career Start Year 2013
Number of shared co-authors 39
Alan Dal Pra
University of Miami Miller School of Medicine
Career Start Year 2010
Number of shared co-authors 35
Himisha Beltran
Dana-Farber Cancer Institute
Career Start Year 2010
Number of shared co-authors 78
John Thoms
Memorial University
Career Start Year 2008
Number of shared co-authors 12
Jure Murgic
University Hospital Center Sestre Milosrdnice
Career Start Year 2008
Number of shared co-authors 12
Arun A Azad
Peter MacCallum Cancer Centre
Career Start Year 2007
Number of shared co-authors 11
Aruz Mesci
Juravinski Cancer Centre
Career Start Year 2006
Number of shared co-authors 3
Alan H Bryce
Mayo Clinic
Career Start Year 2006
Number of shared co-authors 28
Nicholas van As
The Institute of Cancer Research, Royal Marsden NHS Foundation Trust
Career Start Year 2005
Number of shared co-authors 8
Ananya Choudhury
University of Manchester and The Christie NHS Foundation Trust
Career Start Year 2004
Number of shared co-authors 28
Niven Mehra
Radboud university medical center
Career Start Year 2004
Number of shared co-authors 32
Anne Y Warren
Cambridge University Hospitals National Health Service Foundation Trust
Career Start Year 2003
Number of shared co-authors 13
Scott T Tagawa
Meyer Cancer Center, Weill Cornell Medicine-NewYork Presbyterian Hospital
Career Start Year 2003
Number of shared co-authors 37
Zhigang Zhang
Memorial Sloan Kettering Cancer Center
Career Start Year 2001
Number of shared co-authors 10
David T Miyamoto
Massachusetts General Hospital
Career Start Year 2000
Number of shared co-authors 12
Eleni Efstathiou
Houston Methodist Cancer Center
Career Start Year 2000
Number of shared co-authors 30
Johann S de Bono
The Institute for Cancer Research
Career Start Year 1999
Number of shared co-authors 56
Danny Vesprini
University of Toronto, Canada Odette Cancer Centre
Career Start Year 1998
Number of shared co-authors 15
Evan Y Yu
University of Washington and Fred Hutchinson Cancer Research Center
Career Start Year 1997
Number of shared co-authors 50
Anthony M Joshua
The Kinghorn Cancer Centre, St. Vincent's Hospital Sydney
Career Start Year 1997
Number of shared co-authors 28
Simeng Suy
MedStar Georgetown University Hospital
Career Start Year 1996
Number of shared co-authors 34
Stanley K Liu
Odette Cancer Centre, University of Toronto
Career Start Year 1995
Number of shared co-authors 11
Ganesh V Raj
University of Texas Southwestern Medical Center at Dallas
Career Start Year 1994
Number of shared co-authors 25
Lance C Pagliaro
Mayo Clinic
Career Start Year 1993
Number of shared co-authors 16
David I Quinn
USC Norris Comprehensive Cancer Center
Career Start Year 1993
Number of shared co-authors 28
Melania Pintilie
Princess Margaret Cancer Centre, University Health Network
Career Start Year 1993
Number of shared co-authors 13
Bruce Montgomery
Fred Hutchinson Cancer Center, University of Washington
Career Start Year 1990
Number of shared co-authors 37
Celestia S Higano
University of Washington and Fred Hutchinson Cancer Research Center
Career Start Year 1987
Number of shared co-authors 47
Philip W Kantoff
Memorial Sloan Kettering Cancer Center
Career Start Year 1981
Number of shared co-authors 66
Howard I Scher
Memorial Sloan Kettering Cancer Center
Career Start Year 1973
Number of shared co-authors 55

Collaborators

Theodore L DeWeese
Johns Hopkins University School of Medicine
Co-authored papers 43
Danny Y Song
Johns Hopkins University School of Medicine
Co-authored papers 41
Matthew P Deek
Rutgers Robert Wood Johnson Medical School, Rutgers University
Co-authored papers 30
Curtiland Deville
Johns Hopkins University
Co-authored papers 29
Ryan Phillips
Johns Hopkins University
Co-authored papers 26
Stephen Greco
Johns Hopkins University School of Medicine
Co-authored papers 26
Ashley E Ross
Northwestern University
Co-authored papers 26
Felix Y Feng
UCSF Medical Center-Mount Zion
Co-authored papers 25
Kenneth J Pienta
The Brady Urological Institute, Johns Hopkins University School of Medicine
Co-authored papers 22
Daniel E Spratt
University Hospitals Seidman Cancer Center, Case Western Reserve University
Co-authored papers 21
Emmanuel S Antonarakis
The Sidney Kimmel Cancer Comprehensive Cancer Center at Johns Hopkins
Co-authored papers 20
Todd McNutt
Johns Hopkins University School of Medicine
Co-authored papers 18
Amar U Kishan
University of California los angeles
Co-authored papers 17
Piet Ost
Ghent University, GZA Ziekenhuizen
Co-authored papers 15
Michael A Carducci
Johns Hopkins School of Medicine
Co-authored papers 15
Robert E Reiter
David Geffen School of Medicine at university of california los angeles
Co-authored papers 13
Jeffrey J Tosoian
Vanderbilt University Medical Center
Co-authored papers 13
Wolfgang Lilleby
Oslo University Hospital
Co-authored papers 12
Michael L Steinberg
University of California los angeles
Co-authored papers 11
Edward M Schaeffer
Northwestern University Feinberg School of Medicine
Co-authored papers 11
Robert Jeffrey Karnes
Mayo Clinic
Co-authored papers 11
Elai Davicioni
Veracyte Inc.
Co-authored papers 11
Channing J Paller
Johns Hopkins University School of Medicine
Co-authored papers 11
Alejandro Berlin
University of Toronto, Princess Margaret Cancer Centre
Co-authored papers 11
Mario A Eisenberger
Johns Hopkins University
Co-authored papers 11
Paul L Nguyen
Brigham and Women's Hospital and Dana Farber Cancer Institute, Harvard Medical School
Co-authored papers 11
Nicholas G Nickols
University of California, Veteran Affairs Greater Los Angeles Healthcare System
Co-authored papers 11
Eric M Horwitz
Fox Chase Cancer Center
Co-authored papers 10
Bradley J Stish
Mayo Clinic
Co-authored papers 10
Paul C Boutros
University of California los angeles
Co-authored papers 10
Release 1.2